Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD comparison of insulin aspart and biphasic insulin aspart 30, 50, 70 in type 1 diabetes
2005-004775-38Phase 3Completed
- Sponsor
- Medicinsk Afd. M, Århus Sygehus, Nørrebrogade
- Start
- May 2008
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial of insulin aspart, biphasic insulin aspart and Insulin aspart + insulin aspart protamine in diabetes mellitus type 1 (T1D) (4 arms), sponsored by Medicinsk Afd. M, Århus Sygehus, Nørrebrogade. Primary endpoint: Maximal plasma glucose concentration (Cmax) after test meal. Started May 2008; status: completed.
02
Drugs
insulin aspartbiphasic insulin aspartInsulin aspart + insulin aspart protamine
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2005-004775-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004775-38.